|
1
|
Grimm P, Billiet I, Bostwick D, et al:
Comparative analysis of prostate-specific antigen free survival
outcomes for patients with low, intermediate and high risk prostate
cancer treatment by radical therapy. Results from the Prostate
Cancer Results Study Group. BJU Int. 109(Suppl 1): 22–29. 2012.
View Article : Google Scholar
|
|
2
|
Frank SJ, Pisters LL, Davis J, et al: An
assessment of quality of life following radical prostatectomy, high
dose external beam radiation therapy and brachytherapy iodine
implantation as monotherapies for localized prostate cancer. J
Urol. 178:2151–2156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei JT, Dunn RL, Sandler HM, et al:
Comprehensive comparison of healthrelated quality of life after
contemporary therapies for localized prostate cancer. J Clin Oncol.
20:557–566. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Namiki S and Arai Y: Health-related
quality of life in men with localized prostate cancer (Rewiev). Int
J of Urol. 17:125–138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Viani GA, da Silva LG and Stefano EJ:
High-dose conformal radiotherapy reduces prostate cancer-specific
mortality: results of a meta-analysis. Int J Radiat Oncol Biol
Phys. 83:e619–e625. 2012. View Article : Google Scholar
|
|
6
|
Vordermark D, Wulf J, Markert K, et al:
3-D conformal treatment of prostatecancer to 74 Gy vs.
high-dose-rate brachytherapy boost: a cross-sectional
quality-of-life survey. Acta Oncol. 45:708–716. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Joseph KJ, Alvi R, Skarsgard D, et al:
Analysis of health related quality of life of patients with
clinically localized prostate cancer, one year after treatment with
external beam radiotherapy (EBRT) alone versus EBRT and high dose
rate brachytherapy. Radiat Oncol. 3:202008.PubMed/NCBI
|
|
8
|
American Joint Committee on Cancer. Manual
for Staging of Cancer. 4th edition. Lippincott Raven; Philadelphia:
1992
|
|
9
|
Grenabo L, Grundtman S and Hedelin H:
Laparoscopic obturator lymph node dissection in patients with
prostatic cancer. Scand J Urol Nephrol. 29:51–55. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lennernäs B, Rikner G, Letocha H, et al:
External beam radiotherapy of localized prostatic adenocarcinoma.
Acta Oncol. 34:953–958. 1995.PubMed/NCBI
|
|
11
|
Hugosson J, Abrahamsson PA, Ahlgren G, et
al: The risk of malignancy in the surgical margin at radical
prostatectomy reduced almost three-fold in patients given
neo-adjuvant hormone treatment. Eur Urol. 29:413–419. 1996.
|
|
12
|
Aaronson NK, Ahmedzai S, Bergman B, et al:
The European Organization for Research and Treatment of Cancer
QLQ-C30: a quality-of-life instrument for use in international
clinical trials in oncology. J Natl Cancer Inst. 85:365–376. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Van Andel G, Bottomley A, Fosså SD, et al:
An international field study of the EORTC QLQ-PR25: a questionnaire
for assessing the health-related quality of life of patients with
prostate cancer. Eur J Cancer. 44:2418–2424. 2008.
|
|
14
|
Fayers P, Aaronson N, Bjordahl K, et al:
The EORTC QLQ-C30 scoring Manual. 3rd edition. European
Organization for Cancer Research and Treatment of Cancer; Brussels:
2001
|
|
15
|
Michelson H, Bolund C, Nilsson B, et al:
Health-related quality of life measured by the EORTC QLQ-C30 -
reference values from a large sample of Swedish population. Acta
Oncol. 39:477–484. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Osoba D, Rodrigues G, Myles J, et al:
Interpreting the significance of changes in health related
quality-of-life scores. J Clin Oncol. 16:139–144. 1998.PubMed/NCBI
|
|
17
|
Hoffman RM, Gilliland FD, Penson DF, et
al: Cross-sectional and longitudinal comparisons of health-related
quality of life between patients with prostate carcinoma and
matched controls. Cancer. 101:2011–2019. 2004. View Article : Google Scholar
|
|
18
|
Litwin MS, Gore JL, Kwan L, et al: Quality
of life after surgery, external beam irradiation, or brachytherapy
for early-stage prostate cancer. Cancer. 109:2239–2247. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanda MG, Dunn RL, Michalski J, et al:
Quality of life and satisfaction with outcome among prostate-cancer
survivors. N Engl J Med. 358:1250–1261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Potosky AL, Davis WW, Hoffman RM, et al:
Five-year outcomes after prostatectomy or radiotherapy for prostate
cancer: the prostate cancer outcomes study. J Natl Cancer Inst.
96:1358–1367. 2004.PubMed/NCBI
|
|
21
|
Wahlgren T, Nilsson S, Lennernäs B and
Brandberg Y: Promising long-term health related quality of life
after high-dose-rate brachytherapy boost for localized prostate
cancer. Int J Radiat Oncol Biol Phys. 69:662–670. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sprangers MAG and Schwartz CE: Integrating
response shift into health-related quality of life research: a
theoretical model. Soc Sci Med. 48:1507–1515. 1999. View Article : Google Scholar : PubMed/NCBI
|
